Menu

Protein or Perish

A bacteriophage must evolve certain variants of a protein or die.

Aug 31, 2016
Ruth Williams

In phage-assisted continuous evolution (PACE), desired protein variants are produced when a bacteriophage virus's survival depends on evolving the right variants that will interact with a target protein and turn on a gene essential for the virus's survival.

© GEORGE RETSECK To evolve a strong binding affinity between a protein of interest (POI) and a desired target, the gene for the POI (fused to an RNA polymerase subunit) is first encoded into the genome of a bacteriophage lacking a gene (gene III) critical for robust infection of bacteria. These POI-containing viruses are then cultured with E. coli that contain gene III as well as the POI’s desired target (above).

© GEORGE RETSECKInteraction between the POI and target results in recruitment of the E. coli RNA polymerase to the gene III promoter (black), which drives transcription (above). Thus, only those viruses whose POI evolves a strong binding affinity for the target will be able to drive gene III expression, continuously infect the E. coli, and survive.

Read the full story.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.